These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 22971992

  • 1. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
    Shankar S, Marsh L, Srivastava RK.
    Mol Cell Biochem; 2013 Jan; 372(1-2):83-94. PubMed ID: 22971992
    [Abstract] [Full Text] [Related]

  • 2. Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors.
    Roy SK, Chen Q, Fu J, Shankar S, Srivastava RK.
    PLoS One; 2011 Jan; 6(9):e25166. PubMed ID: 21980390
    [Abstract] [Full Text] [Related]

  • 3. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.
    Boreddy SR, Pramanik KC, Srivastava SK.
    Clin Cancer Res; 2011 Apr 01; 17(7):1784-95. PubMed ID: 21350002
    [Abstract] [Full Text] [Related]

  • 4. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
    Huang M, Tang SN, Upadhyay G, Marsh JL, Jackman CP, Srivastava RK, Shankar S.
    Cancer Lett; 2014 Oct 10; 353(1):32-40. PubMed ID: 25050737
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J, Yang R, Dong Y, Chen M, Wang Y, Wang G.
    J Exp Clin Cancer Res; 2019 Jan 28; 38(1):38. PubMed ID: 30691517
    [Abstract] [Full Text] [Related]

  • 8. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
    Shankar S, Ganapathy S, Hingorani SR, Srivastava RK.
    Front Biosci; 2008 Jan 01; 13():440-52. PubMed ID: 17981559
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways.
    Huang M, Tang SN, Upadhyay G, Marsh JL, Jackman CP, Shankar S, Srivastava RK.
    PLoS One; 2014 Jan 01; 9(4):e92161. PubMed ID: 24694877
    [Abstract] [Full Text] [Related]

  • 11. Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
    Liu L, Hou L, Gu S, Zuo X, Meng D, Luo M, Zhang X, Huang S, Zhao X.
    Oncol Rep; 2015 Jan 01; 33(1):297-303. PubMed ID: 25333353
    [Abstract] [Full Text] [Related]

  • 12. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.
    Belguise K, Guo S, Sonenshein GE.
    Cancer Res; 2007 Jun 15; 67(12):5763-70. PubMed ID: 17575143
    [Abstract] [Full Text] [Related]

  • 13. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine.
    Wei R, Penso NEC, Hackman RM, Wang Y, Mackenzie GG.
    Nutrients; 2019 Aug 09; 11(8):. PubMed ID: 31405071
    [Abstract] [Full Text] [Related]

  • 14. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH, Zhan WH, Li ZR, Wang Z, He YL, Peng JS, Cai SR, Ma JP, Zhang CH.
    World J Gastroenterol; 2007 Feb 28; 13(8):1162-9. PubMed ID: 17451194
    [Abstract] [Full Text] [Related]

  • 15. Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways.
    Zhang T, Yang D, Fan Y, Xie P, Li H.
    Apoptosis; 2009 Oct 28; 14(10):1245-54. PubMed ID: 19669889
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L, Wang H, Zhou L, Yu D.
    Toxicol Appl Pharmacol; 2011 Feb 15; 251(1):8-15. PubMed ID: 21092744
    [Abstract] [Full Text] [Related]

  • 19. Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor.
    Ganapathy S, Chen Q, Singh KP, Shankar S, Srivastava RK.
    PLoS One; 2010 Dec 28; 5(12):e15627. PubMed ID: 21209944
    [Abstract] [Full Text] [Related]

  • 20. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
    Sah JF, Balasubramanian S, Eckert RL, Rorke EA.
    J Biol Chem; 2004 Mar 26; 279(13):12755-62. PubMed ID: 14701854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.